| 167701 | 167701 | Effects of Low and Moderate Fat Diets on Lipids, Inflammation and Vascular Reactivity in the Metabolic Syndrome | Completed | No Results Available | Metabolic Syndrome X|Dyslipidemias | Behavioral: Moderate Fat and Moderate Carbohydrate Diet|Behavioral: Low Fat and High Carbohydrate Diet | https://ClinicalTrials.gov/show/NCT00362908 |
| 167702 | 167702 | A Bioequivalence Study of Tobradex AF | Completed | No Results Available | Cataract | Drug: Tobramycin 0.3% / Dexamethasone 0.033% ophthalmic suspension|Drug: Tobramycin 0.3% / Dexamethasone 0.1% ophthalmic suspension (TOBRADEX) | https://ClinicalTrials.gov/show/NCT00362895 |
| 167703 | 167703 | Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer | Completed | Has Results | Non-small Cell Lung Cancer|Recurrent Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer | Drug: docetaxel|Drug: bortezomib|Other: laboratory biomarker analysis|Other: immunoenzyme technique|Other: immunohistochemistry staining method|Other: pharmacological study | https://ClinicalTrials.gov/show/NCT00362882 |
| 167704 | 167704 | Enteroaggregative E.Coli (EAEC) | Terminated | No Results Available | Escherichia Coli Infections | Drug: Levofloxacin|Drug: Placebo|Biological: Enteroaggregative E. coli (EAEC) | https://ClinicalTrials.gov/show/NCT00362869 |
| 167705 | 167705 | Safety and Tolerability Study of AT1001 in Celiac Disease Subjects | Completed | No Results Available | Celiac Disease | Drug: AT1001 | https://ClinicalTrials.gov/show/NCT00362856 |
| 167706 | 167706 | Protein Synthesis in the Brain of Patients With Fragile X Syndrome | Recruiting | No Results Available | Fragile X Syndrome|Healthy Volunteers | | https://ClinicalTrials.gov/show/NCT00362843 |
| 167707 | 167707 | A Study of the Alternative Administration of Ixabepilone and Vinflunine | Completed | No Results Available | Cancer | Drug: vinflunine + ixabepilone | https://ClinicalTrials.gov/show/NCT00362830 |
| 167708 | 167708 | Carboplatin and Temozolomide (Temodar) for Recurrent and Symptomatic Residual Brain Metastases | Completed | Has Results | Brain Tumor|Brain Metastases | Drug: carboplatin|Drug: temozolomide | https://ClinicalTrials.gov/show/NCT00362817 |
| 167709 | 167709 | Tetrabenazine for Partial Responders | Completed | No Results Available | Schizophrenia|Schizoaffective Disorder | Drug: Tetrabenazine | https://ClinicalTrials.gov/show/NCT00362804 |
| 167710 | 167710 | Project RESPECT: The Efficacy of HIV/STD Prevention Counseling | Completed | No Results Available | HIV|Sexually Transmitted Diseases | Behavioral: "Enhanced HIV/STD Counseling:" 4 face-to-face, interctive counseling sessions based on the Theory of Reasoned Action & Health Belief Model|Behavioral: "Brief Counseling" (aka "client-centered counseling"): 2 brief, face-to-face interactive sessions targeted a patient-identified risk behavior|Behavioral: "HIV Prevention Education": 2 brief, didactic sessions informing the patient about HIV/STD prevention strategies | https://ClinicalTrials.gov/show/NCT00362791 |
| 167711 | 167711 | Intensive Insulin Therapy in Non-diabetic Patients With Acute Myocardial Infarction and Hyperglycaemia | Completed | No Results Available | Diabetes|Hyperglycemia|Acute Myocardial Infarction | Drug: Insulin | https://ClinicalTrials.gov/show/NCT00362778 |
| 167712 | 167712 | Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study | Terminated | No Results Available | Type 2 Diabetes|Dyslipidemia | Drug: Fenofibrate|Drug: Metformin|Drug: Placebo | https://ClinicalTrials.gov/show/NCT00362765 |
| 167713 | 167713 | A Pilot Study of Norfloxacin for Hepatopulmonary Syndrome | Completed | No Results Available | Hepatopulmonary Syndrome | Drug: Norfloxacin|Drug: Placebo | https://ClinicalTrials.gov/show/NCT00362752 |
| 167714 | 167714 | Blood Collection From Individuals With Lung Disease for Genetic Studies | Recruiting | No Results Available | Asthma|COPD|Interstitial Lung Disease|Cystic Fibrosis|Lung Cancer | | https://ClinicalTrials.gov/show/NCT00362739 |
| 167715 | 167715 | Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone | Completed | No Results Available | HIV Infections | Drug: Rosiglitazone maleate|Drug: Atazanavir Sulphate|Drug: Atazanavir Sulphate + Rosiglitazone maleate|Drug: Atazanavir Sulphate + Ritonavir|Drug: Atazanavir Sulphate + Ritonavir + Rosiglitazone maleate | https://ClinicalTrials.gov/show/NCT00362726 |
| 167716 | 167716 | Study of Neoadjuvant Ipilimumab in Patients With Urothelial Carcinoma Undergoing Surgical Resection | Completed | No Results Available | Transitional Cell Carcinoma | Drug: Ipilimumab | https://ClinicalTrials.gov/show/NCT00362713 |
| 167717 | 167717 | Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201 | Terminated | No Results Available | Hepatitis B | Drug: Clevudine | https://ClinicalTrials.gov/show/NCT00362700 |
| 167718 | 167718 | GMB: Study of Truvada (TDF+FTC) or Emtricitabine (FTC) Alone Versus HAART Interruption in HIV-Infected Patients With Resistance | Completed | No Results Available | HIV Infections | Drug: Truvada (TDF+FTC) alone|Drug: FTC alone|Procedure: No HAART | https://ClinicalTrials.gov/show/NCT00362687 |
| 167719 | 167719 | Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 Trial | Completed | No Results Available | Hepatitis B | | https://ClinicalTrials.gov/show/NCT00362674 |
| 167720 | 167720 | Low-dose Cortisol in Chronic Posttraumatic Stress Disorder | Terminated | No Results Available | Posttraumatic Stress Disorder | Drug: Cortisol | https://ClinicalTrials.gov/show/NCT00362661 |
| 167721 | 167721 | Developing World Study for RotaTeqâ„¢ (V260-015)(COMPLETED) | Completed | Has Results | Vomiting|Diarrhea|Fever | Biological: RotaTeqâ„¢ - Rotavirus Vaccine, Live, Oral, Pentavalent|Biological: Comparator: Placebo | https://ClinicalTrials.gov/show/NCT00362648 |
| 167722 | 167722 | Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection | Completed | No Results Available | Hepatitis B | Drug: Clevudine | https://ClinicalTrials.gov/show/NCT00362635 |
| 167723 | 167723 | Determinants of Compliance With Glaucoma Therapy | Completed | No Results Available | Open Angle Glaucoma | | https://ClinicalTrials.gov/show/NCT00362622 |
| 167724 | 167724 | Study Evaluating Pantoprazole in Neonates and Preterm Infants With GERD | Completed | Has Results | Gastroesophageal Reflux | Drug: pantoprazole | https://ClinicalTrials.gov/show/NCT00362609 |
| 167725 | 167725 | A Randomized Controlled Trial of Acyclovir Among HIV and HSV-2 Co-Infected Women, Chiang Rai, Thailand | Completed | No Results Available | HIV|Herpes | Drug: acyclovir | https://ClinicalTrials.gov/show/NCT00362596 |
| 167726 | 167726 | Efficacy and Safety of Intranasal Fentanyl in the Treatment of Breakthrough Pain (FT-018-IM) | Completed | No Results Available | Cancer | Drug: Fentanyl | https://ClinicalTrials.gov/show/NCT00362583 |
| 167727 | 167727 | Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma | Completed | No Results Available | Oligoastrocytoma, Mixed|Anaplastic Oligodendroglioma | Drug: Temozolomide | https://ClinicalTrials.gov/show/NCT00362570 |
| 167728 | 167728 | Imaging Techniques in Body MRI | Active, not recruiting | No Results Available | Clinically Indicated MR Imaging | Device: MRI | https://ClinicalTrials.gov/show/NCT00362557 |
| 167729 | 167729 | PROPHYSOME: Pilot Study on Safety of a Weekly Administration of 10mg/kg of AmBisome® in Antifungal Prophylaxis Treatment of Allogeneic Stem-cell Transplantation and Acute Leukaemia | Completed | No Results Available | Leukemia | Drug: Ambisome | https://ClinicalTrials.gov/show/NCT00362544 |
| 167730 | 167730 | Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome | Completed | No Results Available | Idiopathic Membranous Nephropathy|Nephrotic Syndrome | Drug: tacrolimus combined with prednisone | https://ClinicalTrials.gov/show/NCT00362531 |